Form 4: Centene Corp Executive Christopher Koster Reports Stock Transactions
SEC Form 4 Filing
Christopher Koster, Secretary & General Counsel of Centene Corp, reports acquisition and disposal of company stock and derivative securities.
Summary
- On March 15, 2025, Christopher Koster, Secretary & General Counsel of Centene Corp, reported transactions involving Centene's common stock.
- Koster disposed of 4,039 shares of common stock at $58.19 per share to cover taxes upon vesting of restricted stock units.
- He also acquired 85,925 shares of common stock.
- Following these transactions, Koster directly owns 261,707.084 shares of Centene common stock and indirectly owns 100 shares through his spouse.
- The report also details Koster's holdings in derivative securities, including options and phantom stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of insider transactions. The sentiment is neutral as it reflects standard compensation practices and tax obligations.
Future Outlook
The vesting of restricted stock units and performance stock units is subject to future performance conditions and continued employment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and alignment with shareholder interests.
Comparison to Industry Standards
- Tracking insider transactions is a common practice in financial analysis.
- Comparing the ratio of stock options to shares owned with similar companies such as UnitedHealth Group (UNH) or Anthem (ANTM) can provide insights into executive compensation structures.
- The vesting schedules and performance metrics associated with restricted stock units and performance stock units are typical components of executive compensation packages in the healthcare industry.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation and tax-related stock disposals.
- Employees may be indirectly affected by the performance conditions tied to the vesting of performance stock units.
Key Dates
| Date | Description |
|---|---|
| 03/06/2020 | Date related to phantom stock. |
| 12/15/2021 | Date of Performance Stock Option grant. |
| 03/15/2025 | Date of stock transactions. |
| 03/18/2025 | Date of signature on the Form 4. |
| 03/15/2028 | Date of performance stock units vesting. |
| 12/15/2031 | Expiration date of Common Stock Option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.